Melissa G Lechner

15PUBLICATIONS
89CO-AUTHORS
AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursToxicology (incl. clinical toxicology)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 11, 2026
Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome type 1.

|Jun 23, 2025
Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in female patients with breast cancer.

Alexis LeVee, Esther Peluso, Melissa G Lechner

|Feb 18, 2025
Medullary Thyroid Carcinoma and Clinical Outcomes in Heterozygous Carriers of the RET K666N Germline Pathogenic Variant.

Allison T Yip, Teresa H Kim, Esther M Peluso

|Jan 07, 2025
UTX Coordinates TCF1 and STAT3 to Control Progenitor CD8+ T cell Fate in Autoimmune Diabetes.

Ho-Chung Chen, Hsing Hui Wang, Karl B Shpargel

|Dec 16, 2024
Polyfunctional IL-21+ IFNG+ T follicular helper cells contribute to checkpoint inhibitor diabetes mellitus and can be targeted by JAK inhibitor therapy.

Nicole Huang, Jessica Ortega, Kyleigh Kimbrell

|Jun 10, 2024
The Effect of Apalutamide on Thyroid Function in Prostate Cancer Patients.

Clare Moffatt, Melissa G Lechner, Trevor E Angell

Pageof 3

Frequent Collaborators

8 joint publications

Maureen A Su

4 joint publications

Trevor E Angell

3 joint publications

Karen Tsai

2 joint publications

Antoni Ribas